150 related articles for article (PubMed ID: 35676550)
1. Comparable image interpretation of 1- and 3-hour technetium-99m HDP scintigraphy for transthyretin cardiac amyloidosis.
Malhotra S; Singh V; Pilati S; Trepashko D
J Nucl Cardiol; 2022 Aug; 29(4):2020-2023. PubMed ID: 35676550
[No Abstract] [Full Text] [Related]
2. Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
Takahashi K; Morioka H; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S
J Nucl Cardiol; 2023 Oct; 30(5):2215-2221. PubMed ID: 36352088
[No Abstract] [Full Text] [Related]
3. Validation of the Kumamoto criteria for prediction of
Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
[TBL] [Abstract][Full Text] [Related]
4. A case of disappearing amyloid on technetium pyrophosphate scan.
Wang A; Mahmood U; Tang X; Jain D; Pan S
J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
[TBL] [Abstract][Full Text] [Related]
5. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
[No Abstract] [Full Text] [Related]
6. Non-invasive detection and differentiation of cardiac amyloidosis using
Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
[TBL] [Abstract][Full Text] [Related]
7. In the thick of it: hereditary cardiac amyloidosis identified by
Smiley D; Einstein AJ; Chan N; Mintz A; Santana DD; Shetty M; Sekulic M; Goldner K; Wall J; Helmke S; Maurer MS
J Nucl Cardiol; 2023 Jun; 30(3):1258-1262. PubMed ID: 37138173
[No Abstract] [Full Text] [Related]
8. Radiopharmaceutical supply disruptions and the use of
Miller EJ; Campisi R; Shah NR; McMahon S; Cuddy S; Gallegos-Kattan C; Maurer MS; Damy T; Slart RHJA; Bhatia K; Einstein AJ
J Nucl Cardiol; 2022 Oct; 29(5):2748-2760. PubMed ID: 35838892
[No Abstract] [Full Text] [Related]
9. Standardization of
Bokhari S; Morgenstern R; Weinberg R; Kinkhabwala M; Panagiotou D; Castano A; DeLuca A; Kontak A; Jin Z; Maurer MS
J Nucl Cardiol; 2018 Feb; 25(1):181-190. PubMed ID: 27580616
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis.
Waheed A; Dorbala S
Cardiol Clin; 2023 May; 41(2):217-231. PubMed ID: 37003679
[TBL] [Abstract][Full Text] [Related]
11. Serial
Okada A; Tateishi E; Morita Y; Ohta-Ogo K; Izumi C
Circ Heart Fail; 2023 Jan; 16(1):e009595. PubMed ID: 36541213
[No Abstract] [Full Text] [Related]
12. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
Singh V; Falk R; Di Carli MF; Kijewski M; Rapezzi C; Dorbala S
J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
[TBL] [Abstract][Full Text] [Related]
13. Serial scanning with technetium pyrophosphate (
Castaño A; DeLuca A; Weinberg R; Pozniakoff T; Blaner WS; Pirmohamed A; Bettencourt B; Gollob J; Karsten V; Vest JA; Chiuzan C; Maurer MS; Bokhari S
J Nucl Cardiol; 2016 Dec; 23(6):1355-1363. PubMed ID: 26453570
[TBL] [Abstract][Full Text] [Related]
14. Serial Tc-99m MDP scintigraphy demonstrating increasing cardiac uptake over time in a patient with light-chain cardiac amyloidosis.
Lin H; Zhang X; Einstein AJ; Tang G
J Nucl Cardiol; 2022 Aug; 29(4):2024-2028. PubMed ID: 35655112
[No Abstract] [Full Text] [Related]
15. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
[TBL] [Abstract][Full Text] [Related]
16. Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis.
Roshankar G; White GC; Cadet S; Fine NM; Chan D; White JA; Jimenez-Zepeda V; Slomka PJ; Miller RJH
J Nucl Cardiol; 2022 Oct; 29(5):2679-2690. PubMed ID: 34604925
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 1-h with 3-h planar
Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N
Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186
[TBL] [Abstract][Full Text] [Related]
18. False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report.
Zeng Y; Poterucha TJ; Einstein AJ; Zhang Q; Chen Y; Xie H; Wan K; Liang Y; Chen J; Tang G
Medicine (Baltimore); 2021 Apr; 100(17):e25582. PubMed ID: 33907108
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.
Goldstein SA; Lindsay J; Chandeysson PL; Nolan NG
Am J Cardiol; 1989 Mar; 63(11):752-3. PubMed ID: 2538049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
